There has been little historic research and development (R&D) investment in technologies to address developing country health needs. The reasons for this are numerous and include: High capital costs to undertake the R&D and the long time between R&D investment and “commercialisation” of the resulting technology R&D investment not appropriable (in this case, insufficient commercial… Read more